References
Sharretts JM, Kebebew E, Simonds WF. Parathyroid cancer. Semin Oncol. 2010;37(6):580–90.
Michaud L, Burgess A, Huchet V, Lefèvre M, Tassart M, Ohnona J, et al. Is 18F-fluorocholine-PET/CT a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab. 2014;99(12):4531–6.
Lezaic L, Rep S, Sever MJ, Kocjan T, Hocevar M, Fettich J. 18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41(11):2083–9.
Li M, Lu H, Gao Y. FDG-anorectic parathyroid carcinoma with FDG-avid bone metastasis on PET/CT images. Clin Nucl Med. 2013;38(11):916–8.
Feine U, Lietzenmayer R, Hanke JP, Hanke JP, Held J, Wöhrle H, et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med. 1996;37:1468–72.
Conflicts of interest
The authors declare that they have no conflict of interest.
All authors approved the manuscript, and agreed with its submission to EJNMMI.
Ethical approval
All procedures performed in this study were in accordance with the ethical standards and guidelines of the responsible committee on human experimentation.
Informed consent
According to our institutional regulations, the patient gave written consent for medical record publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deandreis, D., Terroir, M., Al Ghuzlan, A. et al. 18Fluorocholine PET/CT in parathyroid carcinoma: a new tool for disease staging?. Eur J Nucl Med Mol Imaging 42, 1941–1942 (2015). https://doi.org/10.1007/s00259-015-3130-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-015-3130-6